New York – SGA, a Boston and New York City-based national architecture, interior design, planning, branded environments and virtual design construction practice, announced that the firm has been selected by Thor Equities Group to redesign 95 Greene Street as a “lab ready” building suited for life sciences, pharmaceutical, green tech, ag-tech, healthcare, and medical tenants in downtown Jersey City, NJ.
For Thor Equities, a New York City-based urban real estate development company, the acquisition provides an opportunity to simultaneously build its dedicated life sciences platform, Thor Sciences, and meet the demand for laboratory and research and development space.
The eight-story, 350,000sf building originally served as a primary manufacturing facility for Colgate Palmolive. Thor Equities Group is purchasing the building from SJP Properties, who acquired the property in partnership with PGIM Real Estate in 1999 and converted it into a Class A office building that was occupied by Merrill Lynch for many years.
Located at the intersection of Greene and York streets, 95 Greene Street is in the heart of Jersey City’s Paulus Hook neighborhood. The property is a short walk from the Exchange Place PATH Station, NY Waterway Ferry and the Exchange Place stop of the new Hudson-Bergen Light Rail system.
In addition to access to public transportation and a highly skilled labor force, 95 Greene Street will feature infrastructure essential to life sciences, healthcare and technology organizations, including an enlarged core to provide generous mechanical shaft space and a high-speed service elevator that links laboratories to an enclosed ground floor loading and storage area.
A rooftop mechanical level provides all new services to the entire building while allowing for the future needs of individual tenants. The modular configuration of mechanical spaces will allow for future expansion as the needs of laboratory tenants adjust with their requirements.